Curis (CRIS) Operating Income (2010 - 2026)
Curis (CRIS) reported Operating Income of -$11.5 million for Q1 2026, down 13.41% on a YoY basis from -$13.3 million in Q1 2025, and down 158.71% quarter-over-quarter from $19.6 million in Q4 2025.
Curis (CRIS) Operating Income (2010 - 2026) Analysis & Trends
Curis has reported Operating Income for 17 years, with the latest figure at -$11.5 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Income fell 13.41% year-over-year to -$11.5 million; the trailing twelve-month figure through Mar 2026 stood at -$7.1 million (up 83.25% YoY), and the FY2025 full-year result was -$5.7 million, up 87.17% from the prior year.
- Operating Income for Q1 2026 stood at -$11.5 million, down from $19.6 million in the prior quarter.
- The five-year high for Operating Income was $19.6 million in Q4 2025, with the low at -$15.1 million in Q1 2022.
- Historically, Operating Income has averaged -$9.6 million across 5 years, with a median of -$11.6 million in 2023.
- Annual changes were most pronounced in 2022 — Operating Income tumbled 71.97% — and 2025, when it jumped 318.13%.
- Curis' Operating Income stood at -$10.2 million in 2022, then decreased by 19.36% to -$12.2 million in 2023, then gained by 26.27% to -$9.0 million in 2024, then jumped by 318.13% to $19.6 million in 2025, then plunged by 158.71% to -$11.5 million in 2026.
- The last three Operating Income figures came in at -$11.5 million (Q1 2026), $19.6 million (Q4 2025), and -$6.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -65.83 Mn |
| 10 | Curis | 8.58 Mn | -6.42 Mn | - | -11.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.52 Mn |
| Dec 31, 2025 | 19.62 Mn |
| Sep 30, 2025 | -6.92 Mn |
| Jun 30, 2025 | -8.25 Mn |
| Mar 31, 2025 | -10.16 Mn |
| Dec 31, 2024 | -8.99 Mn |
| Sep 30, 2024 | -10.57 Mn |
| Jun 30, 2024 | -12.51 Mn |
| Mar 31, 2024 | -12.47 Mn |
| Dec 31, 2023 | -12.20 Mn |
| Sep 30, 2023 | -12.37 Mn |
| Jun 30, 2023 | -12.14 Mn |
| Mar 31, 2023 | -11.63 Mn |
| Dec 31, 2022 | -10.22 Mn |
| Sep 30, 2022 | -12.61 Mn |
| Jun 30, 2022 | -15.06 Mn |
| Mar 31, 2022 | -15.13 Mn |
| Dec 31, 2021 | -12.57 Mn |
| Sep 30, 2021 | -10.05 Mn |
| Jun 30, 2021 | -10.65 Mn |